Aflibercept Treatment Leads to Vascular Abnormalization of the Choroidal Neovascularization

Abstract EN

Recent studies do not support the hypothesis of vascular normalization in the eyes receiving various types of intravitreous antivascular endothelial growth factor (VEGF).

This retrospective study considered 57 eyes of 32 patients with vascular age-related macular degeneration (AMD) undergoing aflibercept treatment.

In this study, we measured the vessel density, Horton-Strahler (HS) ramification ratio (complexity), and the length ratio in 14 eyes with choroidal neovascularization treated with 3–5 Eylea injections, 17 eyes receiving 1-2 injections, and 14 treatment-naïve eyes to the use of swept source optical coherence tomography angiography (OCTA).

Macular 6 × 6 mm scans were acquired using the DRI OCT Triton by a single trained technician.

OCTA images were standardized, binarized, and skeletonized using ImageJ.

Then, the HS analysis of the CNV was performed.

Our data suggest that the vascular density significantly decreases after an anti-VEGF injection 36 and 93 versus 41 and 87 in treatment-naïve patients.

Moreover, CNV before the treatment and in a group with 3–5 injections was more complex than after receiving 1-2 injections.

The branch length was not changed.

Repeated anti-VEGF can lead to vascular abnormalization and further research is needed to confirm the results of this study.